HoLEP vs BipolEP in Management of BPH Patients With Large Prostates
Recruiting
N/A
Interventional Study
Benign Prostatic Hyperplasia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 and older
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 98 (estimated)
- Sponsor
- Assiut University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a non-inferiority prospective randomized comparative clinical trial aiming to prove the non-inferiority of bipolar enucleation of the prostate in comparison to holmium laser enucleation of the prostate in management of benign prostatic hyperplasia patients with large prostates and in turn its feasibility as an alternative procedure in hospitals with limited resources
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>50 years
* Prostate volume \>80 ml
* Failure of or noncompliance with medical treatment
* IPSS \>15
* Qmax \<15 ml/sec
* Urinary retention and fixed catheters with poor results on trial of voiding without catheter
Exclusion Criteria:
* Patients with active UTI
* Prosta…
Contacts